Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion.

Cristina BagaceanChristelle Le DantecChristian BerthouAdrian TempesculHussam SaadAnne BordronMihnea ZdrengheaVictor CristeaNathalie Douet-GuilbertYves Renaudineau

Published in: Clinical epigenetics (2017)

Combining cytogenetic studies with 5-mCyt assessment adds accuracy to CLL patients' prognoses and particularly for those with 13q deletion as a sole cytogenetic abnormality.

Keyphrases

chronic lymphocytic leukemia
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
gene expression
prognostic factors
peritoneal dialysis
patient reported outcomes